💌 XRHealth acquires Swing | US$20bn women's health roadmap | GoRocky buys Kindred
+ lots more in the weekly global briefing on women's health innovation and femtech
Welcome to issue #155 of FutureFemHealth (w/c 20 July 2026) – the market intelligence and media platform for the women's health industry. This is our free weekly global briefing, trusted by 9,920 investors, innovators and ecosystem leaders.
This week's stories reinforce a trend we've been tracking throughout 2026: women's health is becoming part of mainstream healthcare infrastructure rather than remaining a standalone category.
🌟 In this week’s briefing:
🏆 General healthcare expands into women's chronic pain with Swing acquisition
🔄 Men's telehealth platform GoRocky acquires Kindred Women's Health
🔒 Health data privacy back in focus for period apps and wearables
🔥 Coalition calls for $20bn national strategy to close the women’s health gap
Share your news: anna@futurefemhealth.com
💰 Capital flows
📌 US: XRHealth acquires Swing Therapeutics, expanding into digital therapeutics for fibromyalgia and chronic pain. Around 90% of people diagnosed with fibromyalgia are women, making it one of the most female-predominant chronic pain conditions. Swing developed the first FDA-authorised prescription digital therapeutic for fibromyalgia alongside a virtual specialty care platform. The acquisition now brings fibromyalgia care into XRHealth’s broader digital therapeutics platform - another example of women’s health being acquired by general healthcare companies. (Continue reading: FutureFemHealth)
📌 PHILIPPINES: Men’s telehealth platform GoRocky acquires Kindred Women’s Health. CEO Kiyanusch Braun said this move was driven by the fact that more than 60% of GoRocky’s weight management patients are women, despite its men’s health branding. The company has acquired selected assets of Kindred, including its brand, customer base, flagship clinic and parts of its team, after Kindred had previously scaled back operations. GoRocky plans to maintain and expand the Kindred brand into areas including menopause, metabolic health, mental health and sexual health. It’s a deal that highlights how established digital health platforms are using women’s health as a strategic growth opportunity - even if Kindred’s trajectory suggests the challenges of building standalone women’s health businesses. (Continue reading: The Business Manual)
📌 USA: Wildflower Health acquires Every Mother to expand pelvic floor care. Pelvic health issues impact millions of women across pregnancy, postpartum and midlife. Now, women’s health company Wildflower Health has acquired digital pelvic floor platform Every Mother, adding clinically-validated rehabilitation programmes to its women's health platform. The signal is the broader trend towards more comprehensive women's health platforms, rather than standalone point solutions - and a recognition of the importance of pelvic health to our overall health. (Continue reading: Wildflower Health)
📌 US: Eli Lilly invests in smart ring company ŌURA, signalling a broader bet on the emerging GLP-1 support economy. Just weeks after announcing a commercial partnership, Lilly has made an equity investment in the wearable company, which recently revealed that more than 100,000 members are already logging GLP-1 use alongside continuous data on sleep, recovery, stress, menstrual cycles, fertility and pregnancy. While the companies previously stated that no user data would be shared, the investment suggests pharma is looking towards platforms that support adherence, engagement and long-term outcomes while on GLP-1s. For women’s health, it also highlights the growing strategic value of platforms capable of incorporating female physiology into more personalised, connected models of care. (Continue reading: Oura)
📌 UK/US: Juno Bio raises US$3.8m and opens first sequencing laboratory dedicated to women’s health. This investment represents a strong bet on the clinical potential of the vaginal microbiome, as Juno Bio evolves from a direct-to-consumer testing company towards clinical diagnostics and proprietary women’s health datasets. The company uses next-generation sequencing to analyse the vaginal microbiome, screening for around 10,000 bacteria and fungi alongside four common STIs. Having sold more than 20,000 tests, Juno Bio will now use the funding to scale its platform and newly opened CLIA-certified laboratory in California. (Continue reading: Tech.eu)
📌 INDIA: Maternal care startup Promom raises Rs 30 crore (c.US$3.5m) from Fireside Ventures. Promom’s flagship breast pump was developed specifically for Indian mothers following research into breast anatomy, nipple size and lactation flow, reflecting growing demand for locally designed maternal health technology. Alongside its direct-to-consumer business, the company has early clinical adoption and has partnered with 29 hospitals and maternity centres across India. (Continue reading: Economic Times)
🔒 FutureFemHealth Pro
FutureFemHealth Pro is building a growing library of proprietary women’s health market intelligence, including quarterly funding analyses, M&A research, market maps and in-depth sector reports.
Recent reports include:
Q2 2026 Women’s Health Funding Analysis
H1 2026 Women’s Health M&A Analysis
The GLP-1 Support Economy
Chronic Hormonal Monitoring
Urinary Health
🌟 Industry moves and strategic shifts
📌 UK: Mendara launches anonymous birth trauma support app ahead of planned Nesta spin-out. Developed alongside the Birth Trauma Association and incubated within Nesta, the UK’s innovation agency for social good, this platform combines anonymous, facilitator-led peer support with trauma-informed digital tools for women recovering from difficult or traumatic births. AI is used to support facilitator training and quality assurance while keeping the intervention human-led. The broader signal is growing interest in scalable emotional support that helps women process difficult experiences before they reach the threshold for specialist mental health services. (Continue reading: FutureFemHealth)
📌 US: Iris Telehealth launches integrated women’s behavioural health service. Rather than referring women only after they experience significant mental health distress, this new model introduces behavioural health support at predefined milestones throughout the care journey - be that fertility, pregnancy, postpartum or menopause. The launch follows a survey of more than 1,000 women, which found that although 86% felt their healthcare provider recognised the impact of daily responsibilities on their mental health, 30% received no specific treatment or support for stress, while 39% had delayed or avoided behavioural healthcare because of caregiving responsibilities, time constraints or emotional burden. (Continue reading: Iris)
📌 US: Stardust faces scrutiny over health data privacy. Following years of debate over the privacy of period tracking apps, new research from Mozilla claims that Stardust shares users’ sensitive reproductive health information with third-party analytics firm RudderStack, despite marketing itself as privacy-focused. Mozilla assessed six period tracking apps, rating Euki the strongest for privacy, while Flo and Clue also scored relatively well - although both companies disputed aspects of Mozilla’s assessment. (Continue reading: BBC)
📌 GLOBAL: EFF report highlights lack of transparency among wearable makers. This week it’s not just period apps in the spotlight over data privacy. A new report from the Electronic Frontier Foundation (EFF) has found that most leading smartwatch, smart ring and fitness tracker companies still do not publish basic transparency reports explaining how they respond to government requests for user data. While not focused specifically on women’s health, the findings are relevant as wearables like Oura, Whoop, Apple and more increasingly collect menstrual cycle, fertility and other sensitive health data. (Continue reading: EFF)
📄 Policy watch: risks and opportunities
📌 US: Women’s health organisations call for US$20bn national strategy to close the women’s health gap. A coalition led by the Society for Women’s Health Research (SWHR), the American College of Obstetricians and Gynecologists (ACOG) and the Women First Research Coalition has unveiled a roadmap urging Congress to invest US$20 billion over the next decade. The strategy brings together many long-standing priorities: increased funding for women’s health research, stronger clinical training, improved sex-specific data infrastructure, regulatory reforms and greater public awareness. (Continue reading: SWHR)
📌 US: ACOG issues new guidance on collaboration between ob-gyns and doulas. As evidence continues to grow that doulas can improve maternal outcomes, including reducing preterm births, the American College of Obstetricians and Gynecologists (ACOG) has published new guidance encouraging closer collaboration and communication between obstetricians and doulas. (Continue reading: ACOG)
That’s all for this week! If you’ve missed any previous newsletter issues catch them all at futurefemhealth.com and do make sure to follow us on LinkedIn and you can connect with me directly.
Anna
